Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Other Operating Expenses: 2020-2023

Historic Other Operating Expenses for ADC Therapeutics (ADCT) over the last 4 years, with Sep 2023 value amounting to $13.9 million.

  • ADC Therapeutics' Other Operating Expenses rose 176.82% to $13.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $13.6 million, marking a year-over-year increase of 121.20%. This contributed to the annual value of -$73,631 for FY2022, which is 98.96% up from last year.
  • According to the latest figures from Q3 2023, ADC Therapeutics' Other Operating Expenses is $13.9 million, which was down 10.59% from $15.6 million recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Other Operating Expenses peaked at $15.6 million during Q2 2023, and registered a low of -$73.4 million during Q1 2020.
  • Moreover, its 3-year median value for Other Operating Expenses was -$15.3 million (2021), whereas its average is -$8.8 million.
  • Per our database at Business Quant, ADC Therapeutics' Other Operating Expenses slumped by 283.17% in 2021 and then skyrocketed by 178.23% in 2023.
  • Over the past 4 years, ADC Therapeutics' Other Operating Expenses (Quarterly) stood at -$6.1 million in 2020, then plummeted by 186.79% to -$19,373 in 2021, then rose by 13.98% to -$16,665 in 2022, then surged by 176.82% to $13.9 million in 2023.
  • Its Other Operating Expenses stands at $13.9 million for Q3 2023, versus $15.6 million for Q2 2023 and -$15.9 million for Q1 2023.